STEAP1

STEAP1 詳細

英語名Six-transmembrane epithelial antigen of the prostate 1市販薬剤の数0
治験薬の数7ターゲットの別称PRSS24,Six-transmembrane epithelial antigen of prostate 1,STEAP,STEAP1,STEAP Family Member 1,Six Transmembrane Epithelial Antigen Of The Prostate 1,STEAP1 Metalloreductase,Six Transmembrane Epithelial Antigen Of The Prostate,Metalloreductase STEAP1,EC 1.16.1.-,EC:1.16.1.-
研究&開発段階Phase 3 Clinical
英語名Six-transmembrane epithelial antigen of the prostate 1
ターゲットの別称PRSS24,Six-transmembrane epithelial antigen of prostate 1,STEAP,STEAP1,STEAP Family Member 1,Six Transmembrane Epithelial Antigen Of The Prostate 1,STEAP1 Metalloreductase,Six Transmembrane Epithelial Antigen Of The Prostate,Metalloreductase STEAP1,EC 1.16.1.-,EC:1.16.1.-
市販薬剤の数0
治験薬の数7
研究&開発段階Phase 3 Clinical

STEAP1 製品リスト

  • 属性

    Cell (2)Protein (6)

  • 製品ライブラリ

    オンライン (8)

  • Human (7)Rat (1)

  • タグ

    - (2)His Tag & Strep Tag (3)Tag Free (1)His Tag & Avi Tag & Flag Tag (1)His Tag & Flag Tag (1)

  • マーカー

    - (2)Unconjugated (5)Biotin-labeled (1)

STEAP1バックグランド

Six-transmembrane epithelial antigen of the prostate 1 (STEAP1) is an integral membrane protein that is highly up-regulated on the cell surface of several human cancers, making it a promising therapeutic target to manage these diseases. It shares sequence homology with three enzymes (STEAP2-STEAP4) that catalyze the NADPH-dependent reduction of iron(III). Taking into account its high specificity and overexpression in human cancers, STEAP1 is nowadays a promising candidate to be imposed as a therapeutic target.

STEAP1分子の別称

STEAP1, PRSS24, STEAP

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
XaluritamigAMG-509Phase 3 ClinicalAmgen Inc, Xencor IncCastration-Sensitive Prostate Neoplasms; Hormone-Sensitive Prostate Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Sarcoma, Ewing
詳細
89Zr-DFO-MSTP2109APhase 2 ClinicalGenentech Inc, Memorial Sloan Kettering Cancer CenterProstatic Neoplasms
詳細
STEAP1 CART Cell Therapy(PromiCell)Phase 2 ClinicalFred Hutchinson Cancer Research Center, PromiCell Therapeutics IncProstatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
詳細
PRO CAR-201APRO CAR-201APhase 1 ClinicalFred Hutchinson Cancer Research CenterProstatic Neoplasms, Castration-Resistant
詳細
ABBV-969ABBV-969; ABBV969Phase 1 ClinicalAbbvie IncProstatic Neoplasms, Castration-Resistant
詳細
ADRX-0405ADRX-0405Phase 1 ClinicalAdcentrx Therapeutics IncNeoplasms; Solid tumours
詳細
DXC-008DAC-008; DXC-008Phase 1 ClinicalHangzhou Dac Biotech Company LtdProstatic Neoplasms; Sarcoma, Ewing; Solid tumours
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8